TETRAPHASE PHARMACEUTICALS INC Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
TETRAPHASE PHARMACEUTICALS INC had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $151.71 million as of 2014-06-30, per its 10-Q filed 2014-08-12.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-08-12
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $151.71M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $133.24M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $119.72M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $108.42M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-06-30 | $151.71M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $133.24M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $119.72M 10-Q · filed 2014-05-12 |
| 2013-09-30 | $108.42M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $98.30M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $92.88M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $90.08M 10-K · filed 2014-03-06 |